Broman P, Möller E
Department of Medicine, University Hospital, Huddinge, Sweden.
Allergy. 1988 Jul;43(5):321-31. doi: 10.1111/j.1398-9995.1988.tb00425.x.
We have previously reported on peripheral blood lymphocyte (PBL) transformation by allergen, PPD as a control antigen and PHA as a mitogen during and after a preseasonal immunotherapy period. The present report describes similar parameters during and after the ensuing maintenance treatment period. Ten patients with grass pollen rhinitis were treated with Allpyral extract and 10 with Conjuvac two-grass mixture. Lymphocyte transformation responses to grass antigen continued to be low for PBL from patients during the maintenance treatment. Postseasonal values were higher during treatment. In late autumn 1980, when treatment had been stopped, there was a spontaneous fall in lymphocyte stimulation values. Occasional high values were noticed in some patients, two of whom had treatment side effects (urticaria). Clinical data during the whole treatment period (skin prick test, provocation tests, serological parameters, total IgE, grass-specific IgE, grass-specific IgG, pollen counts, symptom scores, clinical effect and adverse reactions) have been published separately.
我们之前曾报道过在季节性免疫治疗期间及之后,外周血淋巴细胞(PBL)对变应原、作为对照抗原的结核菌素纯蛋白衍生物(PPD)以及作为有丝分裂原的植物血凝素(PHA)的转化情况。本报告描述了随后维持治疗期间及之后的类似参数。10例草花粉性鼻炎患者用Allpyral提取物治疗,10例用Conjuvac双草混合物治疗。在维持治疗期间,患者的PBL对草抗原的淋巴细胞转化反应持续较低。治疗期间的季节性后值较高。1980年秋末,治疗停止时,淋巴细胞刺激值出现自发下降。在一些患者中偶尔出现高值,其中2例有治疗副作用(荨麻疹)。整个治疗期间的临床数据(皮肤点刺试验、激发试验、血清学参数、总IgE、草特异性IgE、草特异性IgG、花粉计数、症状评分、临床疗效和不良反应)已另行发表。